CLINICAL_TRIALS
trial_result
· 2020-02-11
Clinical Trial Update: A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
Summary
Clinical trial completion and results posted for corMatrix ECM used in femoral arterial reconstruction in peripheral vascular disease patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elutia Inc. | Conditions: Peripheral Vascular Disease | Status: COMPLETED | Results posted: 2020-02-11